Wednesday, October 8, 2025

11:30 - 12:15

RAMÓN MARGALEF ROOM

---

Overview

Sponsor: Government of Navarra

---

Details

Dr. Freemont will discuss the role of biofoundries in accelerating commercialization and bridging academia and industry. Mr. Pareras from Invivo Fund will discuss the major opportunities expected in the field of synthetic biologic. The Digital Innovation Hub of Navarra (IRIS) is playing a key role in the development of artificial intelligence and data analysis. From this vantage point Dr. Rodríguez Ordóñez how Genomics, Bioinformatics and Next-generation Sequencing are enabling the development of personalized medicine and will expound on the potential for convergence between AI and synthetic biology. Dr. Ceniceros will explain how Inbiolev (LEV2050) is leading in the field of industrial microbiology and the development of customized microorganisms. Dr Galmarini, a passionate entrepreneur, will share Nanogrow’s experience in developing nanoantibodies for the pharmaceutical and animal health industries. The panel will address key questions, including: • How can Spain leverage synthetic biology to lead in the European bioeconomy? • What are the latest trends in investment and public funding for synthetic biology startups? • What regulatory frameworks are needed to support growth in Europe’s bioeconomy? This session will provide attendees with strategic insights and actionable knowledge, showing how synthetic biology is catalyzing the bioeconomy and positioning Spain and Europe as leaders in sustainable biotechnology.

---

Details